Fungabeam Reviews: FungaBeam Introduces an At-Home Light-Based Nail Care Device Designed for Convenience
FungaBeam releases an informational overview outlining how its nail fungus light device is described in company
Press Release Disclaimer: This is a press release distributed through the XPR Media network. It has not been independently verified by our newsroom.

![]()

FungaBeam releases an informational overview outlining how its nail fungus light device is described in company materials, including technology context, usage expectations, and safety considerations related to low-level laser therapy.
Elizabeth, NJ, November 16, 2026 — Fungabeam today launched a clip-on at-home nail light device for U.S. adults that combines 905 nm near-infrared and 470 nm visible blue light in a single unit. Each session runs for 7 minutes per nail and shuts off automatically. The device is one of the few consumer light products built to pair two wavelengths at a fixed distance from the nail.
With the launch, Fungabeam published usage guidance for the device. The guidance covers how long visible change in a nail takes and when to see a doctor first. The company describes the device as part of a nail-care routine that begins with a professional diagnosis.
“We designed Fungabeam around the way nails actually grow, which is slowly,” said Henry Lame, Media Relations Manager at Fungabeam. “Pairing two wavelengths in a device that clips on and times itself makes a long routine easier to keep up, and our guidance is clear that a dermatologist should confirm the cause of a nail change before anyone starts.”
A Common Nail Condition
Fungal nail infection, or onychomycosis, is one of the most common nail conditions doctors see, with prevalence estimated at 1% to 8% of people, according to StatPearls, a clinical reference published by the National Library of Medicine. Toenails are affected far more often than fingernails. Signs such as discoloration, thickening or lifting can also have other causes, which is why diagnosis comes first.
Official Website: getfungabeam.com
What the Device Is
Fungabeam is a handheld, clip-on device about the size of a large remote control. According to the company, it emits two wavelengths, 905 nm infrared and 470 nm visible blue light, in sessions that run 7 minutes per nail and shut off automatically.
The device runs on a rechargeable lithium-ion battery charged over USB, with an initial charge taking about 90 to 120 minutes, according to the company. An indicator light shows red while charging and changes color when the battery is full. The company describes the light as non-thermal, meaning it is not intended to heat the nail, and states that the device is not waterproof.
The device uses low-level light at lower power than the laser procedures offered in some podiatry and dermatology clinics, which heat the nail and are performed by trained staff. Because Fungabeam is used at home without supervision, the company’s guidance puts diagnosis first.
What Low-Level Light Therapy Is
Low-level light therapy, also called photobiomodulation, uses red, near-infrared or blue light at power levels below those that heat or cut tissue. It has been studied in several areas of medicine and is used in some clinical settings, though results vary by condition, device and settings, and researchers are still examining how and when it works.
Blue light in the 400 to 470 nm range has been examined in laboratory research on microorganisms, and near-infrared light penetrates further into tissue than visible light. How either wavelength performs through a thick toenail, and at the power of a consumer device, has not been established in published studies of Fungabeam.
Low-level light therapy, or photobiomodulation, uses light at power levels below those that heat or cut tissue. Blue light in the 400 to 470 nm range has been examined in laboratory research on microorganisms, and near-infrared light reaches further into tissue than visible light. Published studies have not established how either wavelength performs through a thick toenail at consumer-device power, and the company does not claim that light alone changes the cause of a nail condition.

FungaBeam Technology
Understanding the Light-Based Concept One of the central features highlighted in FungaBeam’s marketing is its use of light-based technology. The product’s promotional materials refer to low-level laser therapy (LLLT), blue-light technology, and, in some versions, near-infrared illumination. These descriptions are intended to distinguish the device from conventional nail-care products that rely on topical formulations. Understanding the technology requires distinguishing between the general scientific research surrounding light-based treatments and the evidence available for the specific FungaBeam device.
What the Company States About Results
According to the company, any visible change shows up as clearer nail growing in from the base of the nail, not as a change in the nail that is already there. Because toenails grow slowly, that process is measured in months.
Fungabeam does not publish a timeline for visible change, saying toenail growth differs with age, circulation and general health. The company directs users to a healthcare professional for advice on their own nails.
The company also states that the device is intended only for nails and should not be used on other parts of the body.
How the Device Is Used, According to the Company
According to the company, the device clips over one toenail at a time and runs a 7-minute session before shutting off automatically, so a person treating several nails repeats the session for each one. It is charged over USB between uses and is not designed to be worn in water.
The company describes the routine as one that runs over months rather than days, in line with how slowly toenails grow. It does not describe the device as a one-time procedure, and its materials do not set an end point beyond the clear nail growing in.
Designed for Convenient At-Home Use
Convenience is one of the major themes in FungaBeam’s product positioning.
Many personal-care products require consumers to follow multiple application steps or maintain a routine involving several different products. FungaBeam aims to simplify the process by providing a dedicated device that can be incorporated into an existing daily schedule.
Its promotional materials describe a compact design intended for use on fingernails and toenails.
The general operating process is presented as straightforward:
-
Prepare the affected nail by cleaning and drying the area.
-
Connect or charge the device according to the instructions supplied with the particular model.
-
Position the affected finger or toe in the designated treatment area.
-
Activate the device using its operating controls.
-
Follow the manufacturer’s specified session duration and safety instructions.
Some FungaBeam promotional pages describe sessions lasting approximately seven minutes, while other versions advertise different treatment durations. Users should follow the instructions supplied with their exact model rather than combining specifications from different retailer pages.
The straightforward operating concept is intended to make the device accessible to consumers who prefer uncomplicated personal-care products.
Compact Design and Portability
Portability is another feature highlighted in FungaBeam’s promotional materials.
A compact personal-care device can be easier to store and use than larger equipment requiring dedicated space.
The product is marketed for home use and is positioned as an option for consumers who want to maintain a consistent personal-care routine without arranging repeated visits to a salon or specialist facility solely for routine grooming.
Some product descriptions refer to rechargeable or USB-powered operation. However, power and charging specifications may differ between versions, so consumers should confirm the details with the seller before ordering.
For individuals who travel frequently, a portable design may also be a practical consideration, provided the device can be transported and operated in accordance with the manufacturer’s instructions.
Additional product details and company materials are available through the official FungaBeam website.
How Toenails Grow
A toenail grows from the nail matrix, the tissue under the skin at the base of the nail. New nail pushes the existing nail forward, so a change at the base takes time to reach the tip.
StatPearls, a clinical reference published by the National Library of Medicine, estimates toenail growth at approximately one millimeter per month. At that rate, a full big toenail, which is often around 15 to 20 millimeters long, is replaced over a year or more. The American Academy of Dermatology gives a similar figure of 12 to 18 months for a toenail to regrow.
Because change is gradual, it can be hard to judge by eye from week to week. Dermatologists commonly assess progress by how much clear nail has grown in from the base over several months. Photographs taken in the same light at regular intervals, such as once a month, give a more reliable record than day-to-day impressions, and can be shared with a doctor at a follow-up visit.
StatPearls estimates toenail growth at about one millimeter per month, and the American Academy of Dermatology says a toenail takes 12 to 18 months to regrow. Any visible change appears as clearer nail growing in from the base.
Dermatologists commonly judge progress over several months, and monthly photos taken in the same light give a more reliable record than day-to-day impressions.
Why Diagnosis Comes First
Not every thick or discolored nail is caused by fungus. StatPearls notes that almost half of abnormal-appearing toenails are not fungal. Conditions that can look similar include nail psoriasis, changes after a nail is stubbed or knocked, contact dermatitis, yellow nail syndrome, drug reactions and thyroid conditions.
The American Academy of Dermatology states that a dermatologist may take a sample from the nail and examine it under a microscope to confirm the cause. According to StatPearls, common tests include a potassium hydroxide preparation, a fungal culture and a nail clipping examined in a laboratory, with the laboratory clipping test the most sensitive of the three.
The company directs people with a thickened, discolored or painful nail to a healthcare professional before starting any at-home routine. A light device cannot tell a user what is causing a nail change.
What the Research on Nail Lasers Shows
Published research on lasers for fungal nails remains limited. A 2014 systematic review by Ivan Bristow in the Journal of Foot and Ankle Research examined 12 studies and concluded that “the evidence pertaining to the effectiveness of laser treatment of onychomycosis is limited and of poor methodological quality.” Most studies were small and few included a control group.
The American Academy of Dermatology states that well-designed clinical trials are still needed to identify which lasers are safe and effective for nail fungus.
Most published studies have examined clinic lasers rather than at-home devices, and none examined Fungabeam. Findings on the device category cannot show how a specific product performs. The company states that it has not published a clinical study of the Fungabeam device itself.
At-Home Light Devices and Clinic Options
Fungal nail conditions are commonly managed with one or more of the following:
-
prescription oral medicines, which a doctor prescribes and monitors;
-
prescription topical solutions applied to the nail;
-
in-clinic laser procedures performed by trained staff;
-
at-home light devices.
Each option differs in cost, time and the supervision involved. Prescription medicines are generally the most studied. Fungabeam describes its device as an at-home option that a person can discuss with a doctor, not a replacement for medical care.
Who Should Check With a Doctor First
The company states that people with diabetes, circulation conditions or immune conditions should check with a doctor before using the device. The same applies to people who are pregnant and those who take regular medication.
Foot care is a routine part of diabetes care, and changes in the feet or nails are usually checked by a doctor or podiatrist rather than managed at home alone. The American Academy of Dermatology notes that people with another medical condition, such as diabetes, may benefit from ongoing maintenance care decided with a dermatologist.
Nail Changes Can Return
The American Academy of Dermatology notes that nail fungus can return, sometimes a year or more after clearing. Dermatologists commonly advise keeping feet clean and dry, wearing footwear in shared showers and not sharing nail clippers. The company does not claim the device prevents a return.
The company’s materials do not claim that the device prevents nail changes from returning.
Availability
Fungabeam is available in the United States through the official Fungabeam website, which lists current pricing and return terms.
Frequently Asked Questions
Is Fungabeam a medical treatment?
The company describes it as an at-home light device for nail care that does not replace diagnosis or care from a healthcare professional.
How long is each session?
According to the company, each session is 7 minutes per nail, with automatic shutoff.
How long before a change is visible?
The company does not publish a timeline. A toenail can take 12 to 18 months to grow back in full.
Who should check with a doctor first?
People with diabetes, circulation conditions or immune conditions, people who are pregnant and people who take regular medication should check with a doctor first.
Looking Ahead
Fungabeam said it will keep its usage and diagnosis guidance published alongside the device and update it as research on at-home light devices develops.
“Nail care is a long routine, and the first step should always be a diagnosis,” said Henry Lame, Media Relations Manager at Fungabeam. “Our job at launch is to be clear about what the device is, how it is used and where a doctor’s judgment comes first.”
Sources
-
American Academy of Dermatology, “Nail fungus: Diagnosis and treatment.”
-
StatPearls, National Library of Medicine, entry on onychomycosis.
-
Bristow IR. The effectiveness of lasers in the treatment of onychomycosis: a systematic review. Journal of Foot and Ankle Research, 2014;7:34.
-
U.S. Food and Drug Administration, 510(k) K253960.
About Fungabeam
Based in Ogden, Utah, Fungabeam develops an at-home dual-wavelength light device for nail care and publishes usage and diagnosis guidance for its customers in the United States.
Media Contact
Henry Lame, Media Relations Manager, Fungabeam
Email: support@fungabeam.com
Phone: 833-430-0208
Address: 841 Fairmount Ave, Elizabeth, NJ 07201, USA
Website: getfungabeam.com


